BioSpace News Archive

Cortexyme has successfully completed key components of its phase 1 clinical development program for lead compound COR388

Platelet Biogenesis is the leader in the production of functional human platelets from stem cells and the development of platelet-based therapeutics

Luster Premium White® is getting a dazzling new look for 2018.

Orthopaedic surgeon Craig Miller, M.D., is now using a new technology to offer patients guided personalized surgery for their total shoulder replacements.

The Center for Biosimilars®, an online resource for emerging therapies that focuses on improving patient outcomes, launched its latest video interview series featuring Sheila Frame, vice president, head of biopharmaceuticals, North America, Sandoz, a Novartis Division.

LaVoieHealthScience announced the continued expansion of its strategic communications team with the hiring of Paul Sagan, who is joining LHS as Assistant Vice President, Investor Relations and Corporate Communications.

Biocom announced the appointment of Taylor Crouch, Michael Farrington, Marc T. Morley and Peter Silvester to its board.

Patient-derived organoids, hollow spheres of cells cultured from tumors, can quickly and accurately predict how patients with pancreatic cancer respond to a variety of treatments, facilitating a precision-medicine approach to the deadly disease.

Amgen and The University of Texas MD Anderson Cancer Center announced two multi-year collaboration agreements aimed at accelerating development of a variety of Amgen’s early-stage oncology therapies for patients with leukemia, myelodysplastic syndromes, multiple myeloma, small-cell lung cancer, and other non-lung cancers with small-cell histologies.

Xencor, Inc. announced that company management will present at two upcoming conferences.